Sharps Technology Inc. is a company focused on developing innovative solutions for the safe handling and disposal of sharps waste, particularly in the healthcare sector
Its primary mission is to reduce the risks associated with needle stick injuries and the environmental impacts of improper disposal of sharp medical instruments. The company creates advanced products and systems that enhance safety and efficiency in the management of sharps, aiming to improve patient care while ensuring compliance with health regulations. By prioritizing sustainability and safety, Sharps Technology Inc. contributes to better health outcomes and environmental stewardship.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Sharps (NASDAQSTSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has announced the closing of its firm commitment underwritten public offering. The company secured approximately $20.0 million in gross proceeds from the offering that closed on Jan. 29, 2025. The company granted Aegis Capital Corp. a 45-day option to purchase additional shares of common stock and/or warrants as detailed in the announcement. Aegis acted as the sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
